| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962990 | Vaccine | 2016 | 8 Pages |
Abstract
PPV-23 provided weak protection against all-cause pneumonia in an immunocompetent population, especially among the target population. The additional benefit of PPV-23 in preventing CAP further supports its application in the target population.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Wen-qi Diao, Ning Shen, Pan-xi Yu, Bei-bei Liu, Bei He,